Focuses on inability of Elan Pharmaceuticals Inc. and American Home Products Corp. to develop a vaccine for treatment of Alzheimer's disease in humans. Efforts of Elan to test the proposed vaccine on a mouse model of the disease; Drawbacks of the mouse model; Problems faced by pharmaceutical companies in the vaccine's development.